MGRM · As filed with the SEC
Monogram Technologies cash flow statement, by fiscal year
The statement as Monogram Technologies presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
STATEMENTS OF CASH FLOWS · USD
| USD | FY2024 Year ended Dec 31, 2024 | FY2023 Year ended Dec 31, 2023 | FY2022 Year ended Dec 31, 2022 |
|---|---|---|---|
| Statement | |||
| Operating activities: | |||
| Net loss | (16,328,000) | (13,745,217) | (13,690,947) |
| Adjustments to reconcile net loss to net cash used in operating activities: | |||
| Stock-based compensation | 1,174,000 | 1,558,779 | 743,274 |
| Accrual for contingent settlement liability | 1,500,000 | — | — |
| Other expenses settled with stock issuances | 50,000 | 130,000 | — |
| Loss from change in fair value of common stock make-whole obligation | 45,000 | 44,333 | — |
| Depreciation and amortization | 430,000 | 412,335 | 386,686 |
| Change in fair value of warrant liability | — | (3,088,533) | 3,431,865 |
| Changes in non-cash working capital balances: | |||
| Account receivable | 365,000 | (364,999) | — |
| Prepaid expenses and other current assets | 39,000 | 269,697 | 189,906 |
| Accounts payable | (1,289,000) | 1,799,098 | 214,138 |
| Accrued liabilities | 46,000 | (565,109) | 283,983 |
| Operating lease assets and liabilities, net | — | 7,107 | 21,543 |
| Cash used in operating activities | (13,968,000) | (13,542,509) | (8,419,553) |
| Investing activities: | |||
| Purchases of equipment | (84,000) | (64,913) | (241,203) |
| Cash used in investing activities | (84,000) | (64,913) | (241,203) |
| Financing activities: | |||
| Proceeds from issuances of Common Stock, net | 5,191,000 | 15,330,763 | — |
| Repurchases of Common Stock | (200,000) | — | — |
| Series B Preferred Stock | — | — | 9,615,078 |
| Series C Preferred Stock | — | 147,042 | 3,978,613 |
| Shares issuable upon conversion of Series D Preferred Stock | 11,130,000 | — | — |
| Proceeds from warrant exercise | — | 1,250,000 | — |
| Cash provided by financing activities | 16,121,000 | 16,727,805 | 13,593,691 |
| Increase in cash and cash equivalents during the year | 2,069,000 | 3,120,383 | 4,932,935 |
| Cash and cash equivalents, beginning of the year | 13,589,000 | 10,468,645 | 5,535,710 |
| Cash and cash equivalents, end of the year | 15,658,000 | 13,589,028 | 10,468,645 |
| Non-cash investing and financing activities: | |||
| Increase in right of use asset and lease liability from new lease agreement | — | — | 308,474 |
| Series D Preferred Stock dividends settled through issuance of Common Stock | 151,000 | — | — |
| Issuance costs related to Common Stock Purchase Agreement settled through issuance of Common Stock | — | 247,980 | — |
| Cashless exercise of warrant | — | 926,335 | — |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.